![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
9 Folgen
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
ESF Pharmacists Podcast Dale R
-
- Gesundheit und Fitness
A fortnightly podcast to update ESF pharmacists on the latest news in pharmacy, summarise the evidence of clinical trials, and share some ideas for your patients and help your practice.
-
Introduction to Medical Cannabis
Information about how Cannabis works, different types of cannabinoids as well as importance of terpenes
-
ESF podcast - Leaders Day Summary - Dispensary Efficiencies
A summary of dispensary efficiencies discussed at Leaders Day 5th May 2021.
-
ESF Podcast - February 2021. COVID-19 Vaccines and pharmacies
This episode is a summary of the 2 main COVID-19 vaccines distributed first in Australia, and how pharmacies in Australia will be involved, coinciding with Flu season 2021
-
ESF Podcast episode 6 - 29th Oct 2020 - Diabetes, chronic pain, HCT warning, Activated Probiotics
This episode discusses the new NICE draft guidelines, new warnings on Hydrochlorothiazide, new opinions on metformin use in pre-diabetes, a new once weekly insulin is being trialled, and I talk to Bec from Activated Probiotics about Biome Lift. The draft guideline can be viewed at www.nice.org.uk/guidance/gid-ng10069/documents/draft-guideline
-
Episode 5 - 24th June 2020. Medicinal cannabis, COVID-19 update, deprescribing barriers
A trial to determine medicinal cannabis user's perception of benefit, update on risk of hydroxychloroquine and macrolide combination, theory of immunosuppression for COVID-19 management, and potential barriers to deprescribing as described by GPs.
-
ESF Podcast - 22nd May. Apixaban vs rivaroxaban, SGLT2 inhibitors, ACEI and ARBs & flu risk
Apixaban vs rivaroxaban in non-valvular AF, SGLT2 inhibitors and renal dysfunction risk, ACEI and ARBs use and risk of influenza, update on Medadvisor signups, and a free course from the ASHP.